谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 89 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Case Report: A Case of First-Line Treatment for Rare ROS1 Fusion Mutation Lung Adenocarcinoma with Entrectinib
Yifan Yang, Qing Yi, Wei Yang,Yongzhong Luo,Lemeng Zhang
Frontiers in oncology (2025): 1566687-1566687
引用0浏览0WOS引用
0
0
Enhancing Clinical Precision in Lung Cancer Tissue Biopsy Through Elevated Response-Threshold of an Endoplasmic Reticulum-Targeted Fluorogenic Probe
Zhiyang Yuwen, Xinglong Chen, Kexin Chen, Tenglong Zou,Guojiang Mao,Hongwen Liu,Lemeng Zhang
Materials today Bio (2025): 101654-101654
引用0浏览0WOS引用
0
0
MACC1 is a Potential Prognostic Biomarker for Cancer Immunotherapy in Lung Adenocarcinoma
Changqie Pan, Zhiyuan Zhou, Jun Cao,Lemeng Zhang, Tianli Cheng,Haitao Li, Zhou Jiang,Danhui Huang, Dongqiang Zeng,Yongzhong Luo, Jianhua Wu
Carcinogenesisno. 2 (2025)
引用0浏览0WOS引用
0
0
Research Progress on Novel Antibody Drug Conjugates in Cancer Therapy
Yuning Li, Jialin Su,Shuhua Tan,Yongzhong Luo,Lemeng Zhang
Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciencesno. 2 (2024): 296-304
引用0浏览0WOS引用
0
0
Clinical Significance and Biological Function of Interferon Regulatory Factor 1 in Non-Small Cell Lung Cancer
Jialin Su,Shuhua Tan, Yuning Li, Xinglong Chen, Jiasi Liu,Yongzhong Luo,Changqie Pan,Lemeng Zhang
Frontiers in Pharmacology (2024)
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 90

#Citation: 2672

H-Index: 24

G-Index: 51

Sociability: 6

Diversity: 3

Activity: 21

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn